# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Nov 3, 2025

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2025-11-03
- Accepted by EDGAR: Nov 3, 2025, 16:06 ET
- Period: 2025-11-03
- Accession: 0000875320-25-000230
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532025000230/vrtx-20251103.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532025000230/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532025000230/vrtx-20251103.htm

Filed Nov 3, 2025.
Source: SEC EDGAR, the filing index for accession 0000875320-25-000230. Last ingested by Listed: Nov 14, 2026, 23:22 ET. No prices; not investment advice.
